- Q4 2024 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2024₹1032.3 (+0.28%)Earnings
- Q3 2024 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2024₹887.1 (+0.26%)Earnings
- Q2 2024 Natco Pharma Ltd Earnings Call TranscriptNov 15, 2023₹758.65 (-4.48%)Earnings
- Natco Pharma Ltd Annual Shareholders Meeting TranscriptSep 29, 2023
- Q1 2024 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2023₹876.05 (-1.97%)Earnings
- Q4 2023 Natco Pharma Ltd Earnings Call TranscriptMay 30, 2023₹619.5 (-2.15%)Earnings
- Q3 2023 Natco Pharma Ltd Earnings Call TranscriptFeb 10, 2023₹524.85 (-0.88%)Earnings
- Q2 2023 Natco Pharma Ltd Earnings Call TranscriptNov 11, 2022₹584 (-0.72%)Earnings
- Q1 2023 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2022₹672.85 (-10.35%)Earnings
- Q4 2022 Natco Pharma Ltd Earnings Call TranscriptMay 31, 2022₹690.95 (+3.72%)Earnings
- Q3 2022 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2022₹895.35 (-2.40%)Earnings
- Q2 2022 Natco Pharma Ltd Earnings Call TranscriptNov 12, 2021₹828.7 (+0.55%)Earnings
- Q1 2022 Natco Pharma Ltd Earnings Call TranscriptAug 12, 2021₹1041.45 (+3.06%)Earnings
- Q4 2021 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2021₹1095.8 (+1.25%)Earnings
- Q3 2021 Natco Pharma Ltd Earnings Call TranscriptFeb 12, 2021₹854 (-3.64%)Earnings
- Q2 2021 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2020₹900.9 (-0.63%)Earnings
- Q1 2021 Natco Pharma Ltd Earnings Call TranscriptAug 13, 2020₹813.4 (-4.17%)Earnings
- Q4 2020 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2020₹620.05 (+0.99%)Earnings
- Q3 2020 Natco Pharma Ltd Earnings Call TranscriptFeb 13, 2020₹673.95 (-4.91%)Earnings
- Q2 2020 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2019₹560.15 (-3.19%)Earnings
- Q1 2020 Natco Pharma Ltd Earnings Call TranscriptAug 09, 2019₹551.45 (-0.27%)Earnings
- Q4 2019 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2019₹529.9 (+0.94%)Earnings
Q1 2023 Natco Pharma Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Q1 FY '23 Earnings Conference Call of NATCO Pharma Limited, hosted by Edelweiss Securities.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Kunal Randeria from Edelweiss Securities. Thank you.
And over to you, sir.
Thank you, Michel. Good morning and welcome, everyone. On behalf of Edelweiss Securities, I welcome you all to NATCO Pharma's Q1 FY '23 Earnings Conference Call.
We have with us Mr. Rajeev Nannapaneni, Director and Chief Executive Officer of NATCO Pharma; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. I will hand over the call to Rajesh for his opening remarks.
Over to you, Rajesh.
Thank you, Kunal. Again, good morning, everyone. And welcome to NATCO's conference
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)